|
FBLN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.85815856829686E-13 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.43662859386495E-13 |
| Normal-vs-Stage2 |
7.7715611723761E-16 |
| Normal-vs-Stage3 |
1.00660035862177E-10 |
| Normal-vs-Stage4 |
3.07009999644947E-08 |
| Stage1-vs-Stage2 |
3.645900E-04 |
| Stage1-vs-Stage3 |
2.825700E-02 |
| Stage1-vs-Stage4 |
2.471600E-02 |
| Stage2-vs-Stage3 |
7.55480000000919E-05 |
| Stage2-vs-Stage4 |
2.410000E-04 |
| Stage3-vs-Stage4 |
7.296200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.75670589186439E-12 |
| Normal-vs-AfricanAmerican |
6.18889999999261E-05 |
| Normal-vs-Asian |
3.30939720072365E-11 |
| Caucasian-vs-AfricanAmerican |
5.422800E-01 |
| Caucasian-vs-Asian |
7.908000E-01 |
| AfricanAmerican-vs-Asian |
6.390600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.91813231964488E-12 |
| Normal-vs-Female |
1.13153930669796E-12 |
| Male-vs-Female |
3.936400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.49324996812084E-13 |
| Normal-vs-Age(41-60Yrs) |
2.73414624274437E-12 |
| Normal-vs-Age(61-80Yrs) |
2.2136736888001E-12 |
| Normal-vs-Age(81-100Yrs) |
2.878200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.079400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.964800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.951380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.798200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.251850E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.728400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.805800E-02 |
| Classical-VS-Follicular |
1.413680E-02 |
| Classical-VS-Other |
3.153900E-02 |
| Classical-VS-Normal |
5.09636777223932E-12 |
| Tall-VS-Follicular |
1.057500E-03 |
| Tall-VS-Other |
2.116100E-03 |
| Tall-VS-Normal |
1.04930000022208E-07 |
| Follicular-VS-Other |
7.199200E-01 |
| Follicular-VS-Normal |
1.64557256709941E-12 |
| Other-VS-Normal |
4.75597339288925E-12 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.01474384450739E-13 |
| Normal-vs-N1 |
9.3421936853133E-12 |
| N0-vs-N1 |
2.310000E-01 |
|
|
